Addleshaw Goddard's Manchester corporate team has advised Zeus Capital on the £125m IPO of Quantum Pharma on AIM. The pharmaceutical business plans to have a market capitalisation of £125m upon admission to AIM which is expected to take place on 11 December 2014.

Zeus were advised by corporate finance partner Roger Hart and legal directors Duncan Wilson and Shelley McGivern.

Roger Hart commented: "The IPO market has been more subdued than earlier in the year, but this transaction shows that a good business can come to market."